Greta Ubiali

The specific Bruton tyrosine kinase inhibitor acalabrutinib (ACP-196) shows favorable in vitro activity against chronic lymphocytic leukemia B cells with CD20 antibodies

M. Introna, J. Golay, Greta Ubiali, 2017, Haematologica.

Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies

V. Zoete, O. Michielin, S. Loisel, 2016, The Journal of Immunology.

Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations

A. Rambaldi, R. Bassan, O. Spinelli, 2020, Genes.

Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival

A. Kohlmann, F. Ciceri, E. Angelucci, 2016, Haematologica.